| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
240,830,000 |
| Market
Cap: |
9.39(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$38.96 - $39 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oak Street Health operates primary care centers serving Medicare beneficiaries. Co. maintains a technology-enabled, integrated platform, the Oak Street Platform, to deliver value-based care focused exclusively for Medicare patients. The Oak Street Platform consists of: Care Centers; Interdisciplinary Care Teams; Canopy (Co.'s Purpose-Built, End-to-End Technology); and Care Delivery Approach. Co. targets populations of Medicare beneficiaries in high-density urban and suburban areas, with an optimal market containing more than 50,000 eligible Medicare beneficiaries. Co. serves 13 markets across 8 states, with a collective addressable population of approximately 1.8 million Medicare eligibles.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
10,573,310 |
| Total Sell Value |
$0 |
$0 |
$0 |
$274,584,903 |
| Total People Sold |
0 |
0 |
0 |
7 |
| Total Sell Transactions |
0 |
0 |
0 |
60 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Clem Brian |
Chief Operating Officer |
• – – |
2022-09-01 |
4 |
AS |
$25.37 |
$253,912 |
D/D |
(10,000) |
568,768 |
|
15% |
|
| Myers Griffin |
Chief Medical Officer |
• • – |
2022-08-25 |
4 |
AS |
$28.95 |
$1,447,500 |
I/I |
(50,000) |
4,954,159 |
|
-26% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-08-23 |
4 |
AS |
$25.55 |
$1,028,354 |
I/I |
(40,000) |
1,113,270 |
|
-19% |
|
| Wassong David |
10% Owner |
– – • |
2022-08-19 |
4 |
S |
$24.72 |
$173,040,000 |
I/I |
(7,000,000) |
33,509,640 |
|
12% |
|
| Clem Brian |
Chief Operating Officer |
• – – |
2022-08-17 |
4 |
AS |
$25.69 |
$257,545 |
D/D |
(10,000) |
586,468 |
|
-14% |
|
| Myers Griffin |
Chief Medical Officer |
• • – |
2022-08-11 |
4 |
AS |
$28.93 |
$1,453,853 |
I/I |
(50,000) |
5,004,159 |
|
-24% |
|
| Pykosz Michael T |
Chief Executive Officer |
• • – |
2022-08-11 |
4 |
S |
$29.32 |
$440 |
D/D |
(15) |
7,185,859 |
|
24% |
|
| Clem Brian |
Chief Operating Officer |
• – – |
2022-08-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,700 |
588,768 |
|
- |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-08-09 |
4 |
AS |
$29.08 |
$1,163,128 |
I/I |
(40,000) |
1,153,270 |
|
-30% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-08-08 |
4 |
AS |
$30.48 |
$3,070,381 |
I/I |
(100,729) |
1,193,270 |
|
-32% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-08-05 |
4 |
AS |
$30.12 |
$1,379,430 |
I/I |
(45,794) |
1,293,999 |
|
-31% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-08-04 |
4 |
AS |
$30.01 |
$1,601,498 |
I/I |
(53,366) |
1,339,793 |
|
-29% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-08-03 |
4 |
AS |
$30.24 |
$78,621 |
I/I |
(2,600) |
1,393,159 |
|
-22% |
|
| Pykosz Michael T |
Chief Executive Officer |
• • – |
2022-08-03 |
4 |
AS |
$30.30 |
$96,233 |
D/D |
(3,176) |
7,185,874 |
|
-22% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-08-02 |
4 |
AS |
$30.03 |
$4,429,814 |
I/I |
(147,511) |
1,395,759 |
|
-25% |
|
| Pykosz Michael T |
Chief Executive Officer |
• • – |
2022-08-02 |
4 |
AS |
$30.03 |
$4,730,809 |
D/D |
(157,534) |
7,189,050 |
|
-25% |
|
| Clem Brian |
Chief Operating Officer |
• – – |
2022-08-02 |
4 |
AS |
$30.00 |
$1,200,000 |
D/D |
(40,000) |
596,468 |
|
-25% |
|
| Myers Griffin |
Chief Medical Officer |
• • – |
2022-07-28 |
4 |
AS |
$28.57 |
$5,726,650 |
I/I |
(200,000) |
5,054,159 |
|
-25% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,486 |
3,874,863 |
|
- |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-07-26 |
4 |
AS |
$27.97 |
$1,118,680 |
I/I |
(40,000) |
1,543,270 |
|
-25% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-07-20 |
4 |
AS |
$21.20 |
$3,179,250 |
I/I |
(150,000) |
1,583,270 |
|
-14% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-07-12 |
4 |
AS |
$22.40 |
$1,407,288 |
I/I |
(62,800) |
1,733,270 |
|
-10% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-06-29 |
4 |
AS |
$18.00 |
$11,376 |
I/I |
(632) |
1,796,070 |
|
24% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-06-28 |
4 |
AS |
$18.35 |
$1,791,855 |
I/I |
(96,568) |
1,796,702 |
|
3% |
|
| Price Geoffrey M |
Chief Innovation Officer |
• • – |
2022-05-31 |
4 |
AS |
$18.91 |
$2,268,960 |
I/I |
(120,000) |
1,893,270 |
|
15% |
|
198 Records found
|
|
Page 3 of 8 |
|
|
